|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5596 USD | +0.48% |
|
-1.15% | -3.53% |
| Dec. 18 | RTW Biotech Opportunities announces new investment in Yarrow Bioscience | RE |
| Dec. 17 | VYNE Therapeutics Inc., Yarrow Bioscience, Inc. - M&A Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VYNE THERAPEUTICS INC. | Bio Therapeutic Drugs | +0.48% | -1.15% | -3.53% | -76.88% | -99.72% | 18.63M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- VYNE Stock
- Charts VYNE Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
